Adenosine prevents K+-induced Ca2+ loading: Insight into cardioprotection during cardioplegia

Aleksandar Jovanović, Jose R. Lopez, Alexey E. Alekseev, Win K. Shen, Andre Terzic

Research output: Contribution to journalReview article

22 Citations (Scopus)

Abstract

In clinical practice, hyperkalemic cardioplegia induces sarcolemmic depolarization, and therefore is used to arrest the heart during open heart operations. However, the elevated concentration of K+ that is present in cardioplegic solutions promotes intracellular Ca2+ loading, which could aggravate ventricular dysfunction after cardiac operations. This review highlights recent findings that have established, at the single cell level, the protective action of adenosine against hyperkalemia-induced Ca2+ loading. When it was added to hyperkalemic cardioplegic solutions, adenosine, at millimolar concentrations and through a direct action on ventricular cardiomyocytes, prevented K+-induced Ca2+ loading. This action of adenosine required the activation of protein kinase C, and it was effective only in cardiomyocytes with low diastolic Ca2+ levels. Of importance, adenosine did not diminish the magnitude of K+-induced membrane depolarization, allowing unimpeded cardiac arrest. Taken together, these findings provide direct support for the idea that adenosine is valuable when used as an adjunct to hyperkalemic cardioplegia. This idea has emerged from previous clinical studies that have shown improvement of the clinical outcome after cardiac operations when adenosine or related substances were used to supplement cardioplegic solutions. Further studies are required to define more precisely the mechanism of action of adenosine, and the conditions that may determine the efficacy of adenosine as a cytoprotective supplement to cardioplegia.

Original languageEnglish (US)
Pages (from-to)586-591
Number of pages6
JournalAnnals of Thoracic Surgery
Volume65
Issue number2
DOIs
StatePublished - Feb 1998
Externally publishedYes

Fingerprint

Induced Heart Arrest
Adenosine
Cardioplegic Solutions
Heart Arrest
Cardiac Myocytes
Ventricular Dysfunction
Hyperkalemia
Protein Kinase C
Membranes

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Surgery

Cite this

Adenosine prevents K+-induced Ca2+ loading : Insight into cardioprotection during cardioplegia. / Jovanović, Aleksandar; Lopez, Jose R.; Alekseev, Alexey E.; Shen, Win K.; Terzic, Andre.

In: Annals of Thoracic Surgery, Vol. 65, No. 2, 02.1998, p. 586-591.

Research output: Contribution to journalReview article

Jovanović, Aleksandar ; Lopez, Jose R. ; Alekseev, Alexey E. ; Shen, Win K. ; Terzic, Andre. / Adenosine prevents K+-induced Ca2+ loading : Insight into cardioprotection during cardioplegia. In: Annals of Thoracic Surgery. 1998 ; Vol. 65, No. 2. pp. 586-591.
@article{008012069f524cee86e0ece2776c5834,
title = "Adenosine prevents K+-induced Ca2+ loading: Insight into cardioprotection during cardioplegia",
abstract = "In clinical practice, hyperkalemic cardioplegia induces sarcolemmic depolarization, and therefore is used to arrest the heart during open heart operations. However, the elevated concentration of K+ that is present in cardioplegic solutions promotes intracellular Ca2+ loading, which could aggravate ventricular dysfunction after cardiac operations. This review highlights recent findings that have established, at the single cell level, the protective action of adenosine against hyperkalemia-induced Ca2+ loading. When it was added to hyperkalemic cardioplegic solutions, adenosine, at millimolar concentrations and through a direct action on ventricular cardiomyocytes, prevented K+-induced Ca2+ loading. This action of adenosine required the activation of protein kinase C, and it was effective only in cardiomyocytes with low diastolic Ca2+ levels. Of importance, adenosine did not diminish the magnitude of K+-induced membrane depolarization, allowing unimpeded cardiac arrest. Taken together, these findings provide direct support for the idea that adenosine is valuable when used as an adjunct to hyperkalemic cardioplegia. This idea has emerged from previous clinical studies that have shown improvement of the clinical outcome after cardiac operations when adenosine or related substances were used to supplement cardioplegic solutions. Further studies are required to define more precisely the mechanism of action of adenosine, and the conditions that may determine the efficacy of adenosine as a cytoprotective supplement to cardioplegia.",
author = "Aleksandar Jovanović and Lopez, {Jose R.} and Alekseev, {Alexey E.} and Shen, {Win K.} and Andre Terzic",
year = "1998",
month = "2",
doi = "10.1016/S0003-4975(97)01240-X",
language = "English (US)",
volume = "65",
pages = "586--591",
journal = "Annals of Thoracic Surgery",
issn = "0003-4975",
publisher = "Elsevier USA",
number = "2",

}

TY - JOUR

T1 - Adenosine prevents K+-induced Ca2+ loading

T2 - Insight into cardioprotection during cardioplegia

AU - Jovanović, Aleksandar

AU - Lopez, Jose R.

AU - Alekseev, Alexey E.

AU - Shen, Win K.

AU - Terzic, Andre

PY - 1998/2

Y1 - 1998/2

N2 - In clinical practice, hyperkalemic cardioplegia induces sarcolemmic depolarization, and therefore is used to arrest the heart during open heart operations. However, the elevated concentration of K+ that is present in cardioplegic solutions promotes intracellular Ca2+ loading, which could aggravate ventricular dysfunction after cardiac operations. This review highlights recent findings that have established, at the single cell level, the protective action of adenosine against hyperkalemia-induced Ca2+ loading. When it was added to hyperkalemic cardioplegic solutions, adenosine, at millimolar concentrations and through a direct action on ventricular cardiomyocytes, prevented K+-induced Ca2+ loading. This action of adenosine required the activation of protein kinase C, and it was effective only in cardiomyocytes with low diastolic Ca2+ levels. Of importance, adenosine did not diminish the magnitude of K+-induced membrane depolarization, allowing unimpeded cardiac arrest. Taken together, these findings provide direct support for the idea that adenosine is valuable when used as an adjunct to hyperkalemic cardioplegia. This idea has emerged from previous clinical studies that have shown improvement of the clinical outcome after cardiac operations when adenosine or related substances were used to supplement cardioplegic solutions. Further studies are required to define more precisely the mechanism of action of adenosine, and the conditions that may determine the efficacy of adenosine as a cytoprotective supplement to cardioplegia.

AB - In clinical practice, hyperkalemic cardioplegia induces sarcolemmic depolarization, and therefore is used to arrest the heart during open heart operations. However, the elevated concentration of K+ that is present in cardioplegic solutions promotes intracellular Ca2+ loading, which could aggravate ventricular dysfunction after cardiac operations. This review highlights recent findings that have established, at the single cell level, the protective action of adenosine against hyperkalemia-induced Ca2+ loading. When it was added to hyperkalemic cardioplegic solutions, adenosine, at millimolar concentrations and through a direct action on ventricular cardiomyocytes, prevented K+-induced Ca2+ loading. This action of adenosine required the activation of protein kinase C, and it was effective only in cardiomyocytes with low diastolic Ca2+ levels. Of importance, adenosine did not diminish the magnitude of K+-induced membrane depolarization, allowing unimpeded cardiac arrest. Taken together, these findings provide direct support for the idea that adenosine is valuable when used as an adjunct to hyperkalemic cardioplegia. This idea has emerged from previous clinical studies that have shown improvement of the clinical outcome after cardiac operations when adenosine or related substances were used to supplement cardioplegic solutions. Further studies are required to define more precisely the mechanism of action of adenosine, and the conditions that may determine the efficacy of adenosine as a cytoprotective supplement to cardioplegia.

UR - http://www.scopus.com/inward/record.url?scp=0032004907&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032004907&partnerID=8YFLogxK

U2 - 10.1016/S0003-4975(97)01240-X

DO - 10.1016/S0003-4975(97)01240-X

M3 - Review article

C2 - 9485282

AN - SCOPUS:0032004907

VL - 65

SP - 586

EP - 591

JO - Annals of Thoracic Surgery

JF - Annals of Thoracic Surgery

SN - 0003-4975

IS - 2

ER -